Literature DB >> 18719920

Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes.

Ming-Chi Lu1, K L Yang, Chien-Hsueh Tung, Kuang-Yung Huang, Hui-Chun Yu, Su-Qin Liu, Ning-Sheng Lai.   

Abstract

To investigate the effects of TNF-alpha -308, -238 promoter polymorphisms on TNF-alpha transcription in B27 positive Chinese patients with ankylosing spondylitis (AS). The possible relationship between polymorphisms, MHC antigens, and quantitative TNF-alpha mRNA expression were evaluated. Single nucleotide polymorphisms (SNPS) of TNF-alpha -308 and -238 were performed by PCR-amplification refractory mutation system method (PCR-ARMS) in sixty-seven B27-positive AS patients and 60 HLA-B27 positive healthy controls in Chinese. Quantitative measurement of TNF-alpha mRNA in peripheral blood mononuclear cells was performed with real time RT-PCR. The polymorphisms were correlated to quantitative TNF-alpha mRNA, and MHC antigens (determined by SSP method) in AS patients. The prevalence rate of both -308G/A and -238G/A TNF-alpha promoter polymorphisms in patients were not significantly different from those in normal subjects. However, a significant high LPS-stimulated TNF-alpha mRNA expression was found in peripheral blood mononuclear cells from patients with promoter -308G/A polymorphism (TNF2) as compared to those in -308G/G genotype (TNF1). Furthermore, -308G/A polymorphism in patients was found to be tightly associated with distinct haplotypes of A33/B58/Cw10 [12 out of 14 -308G/A patients (85.7%) versus none in 53 -308G/G patients], independent of B27 antigen. HLA-A33-B58-Cw10 haplotypes associated TNF-alpha promoter -308G/A polymorphism might play an important role in disease pathogenesis of AS in Chinese population, partially related to a driving force of a higher TNF-alpha production. It confirms once again the importance and complexity of MHC related molecules in disease pathogenesis of AS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719920     DOI: 10.1007/s00296-008-0671-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  31 in total

Review 1.  Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

Authors:  R D Allen
Journal:  Mol Immunol       Date:  1999 Oct-Nov       Impact factor: 4.407

2.  Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis.

Authors:  A Milicic; F Lindheimer; S Laval; M Rudwaleit; H Ackerman; P Wordsworth; T Hohler; M A Brown
Journal:  Genes Immun       Date:  2000-10       Impact factor: 2.676

3.  Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis-- correlation with clinical activity.

Authors:  Su-Qin Liu; Hui-Chun Yu; Yong-Zhang Gong; Ning-Sheng Lai
Journal:  J Rheumatol       Date:  2006-06       Impact factor: 4.666

4.  Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis.

Authors:  E L Kaijzel; M V van Krugten; B M Brinkman; T W Huizinga; T van der Straaten; J M Hazes; H W Ziegler-Heitbrock; S A Nedospasov; F C Breedveld; C L Verweij
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

5.  Genetic markers may predict disease behavior in patients with ulcerative colitis.

Authors:  M Roussomoustakaki; J Satsangi; K Welsh; E Louis; G Fanning; S Targan; C Landers; D P Jewell
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

6.  A polymorphic variation in a putative regulation box of the TNFA promoter region.

Authors:  S D'Alfonso; P M Richiardi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region.

Authors:  L A Rubin; C I Amos; J A Wade; J R Martin; S J Bale; A H Little; D D Gladman; G E Bonney; J D Rubenstein; K A Siminovitch
Journal:  Arthritis Rheum       Date:  1994-08

8.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.

Authors:  F Pociot; L Briant; C V Jongeneel; J Mölvig; H Worsaae; M Abbal; M Thomsen; J Nerup; A Cambon-Thomsen
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

9.  Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy.

Authors:  A A Grom; K J Murray; L Luyrink; H Emery; M H Passo; D N Glass; T Bowlin; C Edwards
Journal:  Arthritis Rheum       Date:  1996-10

10.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  10 in total

1.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

Review 2.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

Review 3.  Recent studies on the genetic basis of ankylosing spondylitis.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 4.  Lack of association between TNF polymorphism and ankylosing spondylitis susceptibility in HLA-B27-positive population: a meta-analysis.

Authors:  Yanyan Bai; Hongsheng Sun; Naiwen Hu; Dongxia Liu; Na Zhao; Xia Wang
Journal:  Eur Spine J       Date:  2021-06-08       Impact factor: 3.134

5.  Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patients.

Authors:  Zhiming Lin; Qu Lin; Zetao Liao; Qiuxia Li; Fucheng Zhang; Qiujing Wei; Shuangyan Cao; Jieruo Gu
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

6.  Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis.

Authors:  Ning-Sheng Lai; Jian-Liang Chou; Gary C W Chen; Su-Qin Liu; Ming-Chi Lu; Michael W Y Chan
Journal:  Mol Biol Rep       Date:  2014-02-16       Impact factor: 2.316

7.  Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment.

Authors:  Qu Lin; Zhiming Lin; Jieruo Gu; Feng Huang; Tianwang Li; Qiujing Wei; Zetao Liao; Shuangyan Cao; Yingjuan Jiang; Jinxian Huang
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

8.  Genetic polymorphisms associated with the inflammatory response in bacterial meningitis.

Authors:  Fabrícia Lima Fontes; Luíza Ferreira de Araújo; Leonam Gomes Coutinho; Stephen L Leib; Lucymara Fassarella Agnez-Lima
Journal:  BMC Med Genet       Date:  2015-08-28       Impact factor: 2.103

9.  The effect of single nucleotide polymorphisms in the tumor necrosis factor-α gene on reproductive performance and immune function in dairy cattle.

Authors:  Yurie Kawasaki; Yuka Aoki; Fumie Magata; Akio Miyamoto; Chiho Kawashima; Takuo Hojo; Kiyoshi Okuda; Koumei Shirasuna; Takashi Shimizu
Journal:  J Reprod Dev       Date:  2014-02-24       Impact factor: 2.214

10.  Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation.

Authors:  Fa-Hong Yan; Mei Wang; Jian-Feng Yao; Er-Lie Jiang; Ming-Zhe Han
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.